Alpha-lipoic acid supplementation and diabetes.

Area of Science:

• Biochemistry
• Metabolic Disorders
• Nutritional Science

Background:

• Diabetes mellitus is linked to increased oxidative stress and impaired antioxidant defenses, elevating cardiovascular disease risk.
• Alpha-lipoic acid (LA), a natural dithiol compound, is vital for mitochondrial enzymes and possesses significant antioxidant and pharmacological properties.
• LA biosynthesis declines with age and in compromised health, suggesting a potential therapeutic role.

Purpose of the Study:

• To review the efficacy of alpha-lipoic acid (LA) in managing type 1 and type 2 diabetes.
• To assess the benefits of LA concerning glycemic control, insulin sensitivity, oxidative stress, and neuropathy in diabetic patients.

Main Methods:

• Literature review focusing on studies investigating alpha-lipoic acid in diabetes.
• Analysis of LA's pharmacological actions, including glycemic improvement and mitigation of toxicities.
• Evaluation of LA's antioxidant mechanisms, such as free radical termination and enhancement of endogenous antioxidants.

Main Results:

• Alpha-lipoic acid improves glycemic control and polyneuropathy in diabetic patients.
• LA acts as a potent antioxidant, directly neutralizing free radicals and increasing glutathione and vitamin C levels.
• Supplementation with LA appears most beneficial for patients experiencing diabetic neuropathy.

Conclusions:

• Alpha-lipoic acid demonstrates multifaceted benefits for diabetes management, acting both physiologically and pharmacologically.
• LA's antioxidant and insulin-sensitizing effects offer potential therapeutic advantages, especially for diabetic complications like neuropathy.
• Further investigation into LA as a therapeutic agent for diabetes and related oxidative stress conditions is warranted.